Top Markets
Coin of the day
Nichi-Iko Pharmaceutical Co., Ltd. Nichi-Iko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

4541
Rang in Aktien #8954
Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports,... Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports, and sells a wide variety of pharmaceutical products. Operating through its Sagent Group and Nichi-Iko Group segments, the company primarily focuses on the development and production of generic drugs. Its extensive product line encompasses antidiabetic, antacid, and antireflux agents, as well as beta-blockers, hypnotics, sedatives, angiotensin II antagonists (including combinations with diuretics), dyslipidemic agents, and calcium antagonists. These offerings target conditions affecting the circulatory, digestive, respiratory, central, and peripheral nervous systems, among others. Beyond pharmaceuticals, the company is also involved in packaging design and exports its products internationally. Established in 1947 as Nihon Iyakuhin Kogyo Co., Ltd., the firm officially became Nichi-Iko Pharmaceutical Co., Ltd. in 2005 and is headquartered in Toyama, Japan.
Aktienkurs
$0.22167204
Zuletzt synchronisiert: 2024-08-21
Marktkapitalisierung
$1.13B
Veränderung (1 Tag)
1.08%
Veränderung (1 Jahr)
0.00%
Land
JP
Handel Nichi-Iko Pharmaceutical Co., Ltd. (4541)

Kategorie

Aktien-Split-Historie für Nichi-Iko Pharmaceutical Co., Ltd. (4541)
Die Aktie Nichi-Iko Pharmaceutical Co., Ltd. (Symbol: 4541) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 29, 2026 statt.
Eine 4541-Aktie, die vor dem Aug 29, 2026 gekauft wurde, entspricht heute 0 4541-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber